Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Buspirone's efficacy in organic-induced aggression

S W Stanislav1, T Fabre, M L Crismon

  • 1College of Pharmacy, University of Texas at Austin 78712.

Journal of Clinical Psychopharmacology
|April 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Severe adverse events during medical and surgical treatment of hip and knee prosthetic joint infections.

Infectious diseases now·2020
Same author

One-stage versus two-stage prosthesis replacement for prosthetic knee infections.

Medecine et maladies infectieuses·2019
Same author

Treatment of defects in the tip and palmar surface of the fingers.

Hand surgery & rehabilitation·2018
Same author

Reproducibility of low-dose stereography measurements of femoral torsion after IM nailing of femoral shaft fractures and in intact femurs.

Orthopaedics & traumatology, surgery & research : OTSR·2016
Same author

EOS-based cup navigation: Randomised controlled trial in 78 total hip arthroplasties.

Orthopaedics & traumatology, surgery & research : OTSR·2016
Same author

Proximal ulnar fractures in adults: a review of 163 cases.

Injury·2015
Same journal

Aripiprazole Withdrawal-Associated Restless Legs Syndrome During Clozapine Treatment in an Adolescent With Schizoaffective Disorder: A Case Report.

Journal of clinical psychopharmacology·2026
Same journal

Salute to Our Reviewers.

Journal of clinical psychopharmacology·2026
Same journal

Article Selected to Receive the Mitchell B. Balter Award for Publications in 2025.

Journal of clinical psychopharmacology·2026
Same journal

Pregnancy Outcomes After First-Trimester Exposure to Vortioxetine: Prospective Outcomes From the MGH National Pregnancy Registry for Psychiatric Medications.

Journal of clinical psychopharmacology·2026
Same journal

Salute to Our Reviewers.

Journal of clinical psychopharmacology·2026
Same journal

Serotonin Syndrome Associated With Polypharmacy in an Elderly Patient With Dementia and Parkinson Disease.

Journal of clinical psychopharmacology·2026
See all related articles

Buspirone therapy showed promise in reducing aggressive behaviors in psychiatric patients with organic conditions, particularly traumatic brain injury. This study suggests buspirone is well-tolerated and effective for such patients.

Area of Science:

  • Psychiatry
  • Neuroscience
  • Pharmacology

Background:

  • Organic-related psychiatric diagnoses present complex behavioral challenges.
  • Aggressive behaviors often complicate treatment in these patient populations.
  • Buspirone is an anxiolytic medication with potential applications beyond its primary indications.

Purpose of the Study:

  • To identify and characterize hospitalized patients with organic psychiatric diagnoses receiving buspirone.
  • To assess the efficacy of buspirone in mitigating aggressive behaviors in this cohort.
  • To evaluate the tolerability of buspirone therapy in patients with organic psychiatric conditions.

Main Methods:

  • Retrospective medical record review of patients treated with buspirone over 36 months.

Related Experiment Videos

  • Analysis of monthly behavioral therapy records to quantify aggressive behaviors.
  • Inclusion criteria: hospitalized patients with organic psychiatric diagnoses and buspirone therapy.

    • Main Results:

    • Twenty subjects (age 15-55) with organic psychiatric diagnoses received buspirone.
    • 90% of subjects with available data (n=10) showed behavioral improvement.
    • 60% of subjects demonstrated at least a 50% reduction in behavioral symptoms.

    Conclusions:

    • Buspirone appears well-tolerated and effective for aggressive and maladaptive behaviors in patients with organic psychiatric illness, especially traumatic brain injury.
    • Findings suggest buspirone as a potential therapeutic option for this patient group.
    • Further validation through prospective, controlled trials is warranted.